Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate

Human Gene Therapy

Volumn 9, Issue 17, 1998, Pages 2537-2544

  Beauséjour, Christian M ^a   Le, Ngoc Loan Oanh ^a   Létourneau, Sylvain ^b   Cournoyer, Denis ^b   Momparler, Richard L ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTARABINE; CYTIDINE DEAMINASE; DIHYDROFOLATE REDUCTASE; METHOTREXATE; PHENYLALANINE; SERINE; VIRUS VECTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CISTRON; CONTROLLED STUDY; DRUG RESISTANCE; GENE TRANSFER; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; RETROVIRUS;

ANIMALIA; ARA; MURINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 2442770054     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349850019373     Document Type: Article

References (43)

1. ALLAY, J.A., DUMENCO, L.L., KOC, O.N., LIU, L., and GERSON, S.L. (1995). Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85, 3342-3351.
2. BANERJEE, D., ZHAO, S.C., LI, M.-X., SCHWITZER, B.I., MINEISHI, S., and BERTINO, J.R. (1994a). Gene therapy. Utilizing drug resistance genes: A review. Stem Cells 12, 378-385.
3. BENERJEE, D., SCHWEITIZER, B.I., VOLKENANDT, M., LI, M.-X., WALTHAM, M., MINEISHI, S., ZHAO, S.-C., and BERTINO, J.R. (1994b). Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance. Gene 139, 269-284.
4. BERTINO, J.R., PERKINS, J.P., and JOHNS, D.G. (1965). Purification and properties of dihydrofolate reductase from Ehrlich ascites carcinoma cells. Biochemistry 4, 839-846.
5. CADMAN, E., and EIFERMAN, F. (1979). Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside. J. Clin. Invest. 64, 788-797.
6. CZAYKOWSKI, P.M., SAMUELS, T., and OZA, A. (1997). A durable response to cytarabine in advanced breast cancer. Clin. Oncol. 9, 181-183.
7. D'HONDT, V., CARUSO, M., and BANK, A. (1997). Retrovirus-mediated gene transfer of the multidrug-associated protein cDNA protects cells from chemotherapeutic agents. Hum. Gene Ther. 8, 1645-1751.
8. EDELSTEIN, M., and VALERIOTE, F. (1985). Cytosine arabinoside in experimental combination therapy. Semin. Oncol. 12(2), 75-83.
9. EDELSTEIN, M., VIETTI, T., and VALERIOTE, F. (1975). The enhanced cytotoxicity of combination of 1-β-D-arabinofuranosylcytosine and methotrexate. Cancer Res. 35, 1555-1558.
10. ELIOPOULOS, N., BOVENZI, V., MOMPARLER, L.F., COURNOYER, D., and MOMPARLER, R.L. (1996). Gene transfer of human cytidine deaminase cDNA into murine cells confers resistance to cytosine arabinoside, 5-aza-2′-deoxycytidine and 2,2′-difluorodeoxycytidine. 9th NCI-EORTC Symposium on New Drugs in Cancer Therapy. Ann Oncol 7(Suppl. 1), 58.
11. ELIOPOULOS, N., COURNOYER, D., and MOMPARLER, R.L. (1988). Drug resistance to 5-aza-2′-deoxycytidine, 2′,2′-difluorodeoxycytidine and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. Cancer Chemother. Pharmacol. (in press).
12. EMERMAN, M., and TEMIN, H.H. (1984). Genes with promoters in retrovirus vectors can be independently supressed by an epigenetic mechanism. Cell 39, 459-467.
13. EMERMAN, M., and TEMIN, H.H. (1986). Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol. Cell. Biol. 6, 792-800.
14. ERCIKAN-ABALI, E.A., MINEISHI, S., TONG, Y., NAKAHARA, S., WALTHAM, M.C., BANERJEE, D., CHEN, C., SADELAIN, M., and BERTINO, J.R. (1996). Active site-directed double mutants of dihydrofolate reductase. Cancer Res. 56, 4142-4145.
15. FLASSHOVE, M., BANERJEE, D., BERTINO, J.R., and MOORE, M.A.S. (1995). Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant. Leukemia 9(Suppl. 1), S34-S37.
16. GALIPEAU, J., BENAIM, E., SPENCER, H.T., BLAKELEY, R.L., and SORRANTINO, B.P. (1997). A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and p-glycoprotein effluxed drugs. Hum. Gene Ther. 8, 1773-1783.
17. GHATTAS, I., SANES, J.R., and MAJORS, J.E. (1991). The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and embryos. Mol. Cell. Biol. 11, 5848-5859.
18. HOOVIS, M.L., and CHU, M.Y. (1973). Enhancement of the antiproliferative action of 1-β-D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y). Cancer Res. 33, 521-525.
19. JANG, S.K., DAVIES, M.D., KAUFMAN, R.J., and WIMMER, E. (1989). Initiation of protein synthesis by internal entry of ribosomes into the ′ nontranslated region of encephalmyocarditis virus RNA in vivo. J. Virol. 63, 1651-1660.
20. KOC, O.N., ALLAY, J.A., LEE, K., DAVIS, B.M., REESE, J.S., and GERSON, S.L. (1996). Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance. Semin. Oncol. 23, 46-65.
21. LALIBERTÉ, J., and MOMPARLER, R.L. (1994). Human cytidine deaminase: Purification of enzyme, cloning and expression of its cDNA. Cancer Res. 54, 5401-5407.
22. LÉTOURNEAU, S., GREENBAUM, M., and COURNOYER, D. (1996). Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in primary mouse hematopoietic progenitor cells. Hum. Gene Ther. 7, 831-840.
23. LI, M.X., BANERJEE, D., ZHAO, S.C., SCHWEITZER, B.I., MINEISHI, S., GILBOA, E., and BERTINO, J.R. (1994). Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction. Blood 11, 3403-3408.
24. LIE, S.O., and SLORDAHL, S. (1985). High-dose cytosine arabinoside in the treatment of childhood malignancies. Semin. Oncol. 12(Suppl. 3), 160-165.
25. MOMPARLER, R.L., ELIOPOULOS, N., BOVENZI, V., LETOURNEAU, S., GREENBAUM, M., and COURNOYER, D. (1996). Resistance to cytosine arabinoside by retroviral-mediated aene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Cancer Gene Ther. 3, 331-338.
26. MOMPARLER, R.L., BOUFFARD, D.Y., MOMPARLER, L.F., DIONNE, J., BELANGER, K., and AYOUB, J. (1997). Pilot phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer. Anti-Cancer Drugs 8, 358-368.
27. MORGAN, R.A., COUTURE, L., ELROY-STEIN, O., RAGHEB, J., MOSS, B., and ANDERSON, W.F. (1992). Retroviral vectors containing putative internal ribosome entry sites; development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res. 20, 1293-1299.
28. MORITZ, T., MACKAY, W., GLASSNER, B.J., WILLIAMS, D.A., and SAMSON, L. (1995). Retrovirus-mediated expression of DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res. 55, 2608-2614.
29. OLSEN, J.C., JOHNSON, L.G., WONG-SUN, M.L., MOORE, K.L., SWANSTROM, R., and BOUCHER, R.C. (1993). Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells; effect of selectable marked sequences on long-term expression. Nucleic Acids Res. 21, 663-669.
30. OSBORN, C., and HUENNEKENS, F.K. (1958). Enzymatic reduction of dihydrofolic acid. J. Biol. Chem. 233, 969-974.
31. O'SHAUGHNESSY, J.A., COWAN, K.H., and NEINHUIS, A.W. (1994). Retroviral mediated transfer of the human multi drug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer. Hum. Gene Ther. 5, 891-911.
32. POSSINGER, K. (1995). Gemcitabine in advanced breast cancer. Anti-Cancer Drugs 6(Suppl. 6), 55-59.
33. RAFFERTY, J.A., HICKENSON, I., CHINNASAMY, N., LASHFORD, L.S., MARGISON, G.P., DEXTER, T.M., and FAIRBAIRN, L.J. (1996). Chemoprotection of normal tissues by transfer of drug resistance genes. Cancer Metastasis Rev. 15, 365-383.
34. RIVKIN, S.E., GREEN, S., METCH, B., CRUZ, A.B., ABELOFF, M.D., JEWELL, W.R., COSTANZI, J.J., FARRAR, W.B., MINTON, J.P., and OSBORNE, K.C. (1994). Adjuvant CMFVP vs tamoxifen vs concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: A Southwest Oncology Group study. J. Clin. Oncol. 12, 2078-2085.
35. SCHWEITZER, B.I., SRIMATKANDADA, S., GRITSMAN, H., SHERIDAN, R., VENKATARAGHAVAN, R., and BERTINO, J.R. (1989). Probing the role of two hydrophobic active site residues in the human dihydrofolate reductase by site-directed mutagenesis. J. Biol. Chem. 264, 20786-20795.
36. SHEPHERD, F.A. (1995). Phase II trials of single-agent activity of gemcitabine in patients with advanced non-small cell lung cancer: An overview. Anti-Cancer Drugs 6(Suppl. 6), 19-25.
37. SORRENTINO, B.P., BRANDT, S.J., BODINE, D., GOTTESMAN, M., PASTAN, I., CLINE, A., and NIENHUIS, A.W. (1992). Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science 257, 99-103.
38. SUGIMOTO, Y., AKSENTIJEVIVH, I., GOTTESMAN, M.M., and PASTAN, I. (1994). Efficient expression of drug-selectable genes in retroviral vectors under control of an internal ribosome entry site. Biotechnology 12, 694.
39. SUGIMOTO, Y., AKSENTIJEVIVH, I., MURRAY, G., BRADY, R.O., PASTAN, I., and GOTTESMAN, M.M. (1995). Retroviral coexpression of a multidrug resistance gene (MDR1) and human α-galactosidase A for gene therapy of fabry disease. Hum. Gene Ther. 6, 905-915.
40. SUZUKI, M., SUGIMOTO, Y., TSUKAHARA, S., OKOCHI, E., GOTTESMAN, M.M., and TSURUO, T. (1997). Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy. Clin. Cancer Res. 3, 947-954.
41. WARD, M., RICHARDSON, C., PIOLI, P., SMITH, L., PODDA, S., GOFF, S., HESDORFFFER, C., and BANK, A. (1994). Transfer and expression of the human multiple drug resistance gene in human CD34+ cells. Blood 84, 1408-1414.
42. ZHAO, S.C., LI, M.-X., BANERJEE, D., SCHWIETIZER, B.I., MINEISHI, S., GIBOA, E., and BERTINO, J.R. (1994). Long term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double copy vector retrovirus containing a mutant dihydrofolate reductase. Cancer Gene Ther. 1, 27-33.
43. ZHAO, S.C., BANERJEE, D., MINEISHI, S., and BERTINO, J.R. (1997). Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA. Hum. Gene Ther. 8, 903-909.